• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

GeneEd Releases Comprehensive Database of Disease State and Therapeutic Area (TA) E-Learning

Posted on: Monday, 22 May 2006, 06:04 CDT

GeneEd, Inc.:

-- Five Years in the Making, GeneEd's Database of Disease State E-Learning Encompasses the Top 40 Diseases and Top 10 Therapeutic Areas Pursued by All Pharmaceutical, Biotechnology, Medical Device and Health-Care Organizations.

GeneEd, Inc., the leading provider of e-Learning solutions for the life science and health-care industries, today announced that it has delivered over 130 new e-learning courses covering the anatomy & physiology, etiology, pathophysiology, prognosis, diagnosis and treatment of a comprehensive list of disease states, ranging from atrial fibrillation to small-cell lung cancer. (http://www.geneed.com/catalog/ta.html). This database of disease state training represents one of the most comprehensive catalogs of animated expositions created in medical health. Over five years in the making, the content has already been validated at major pharmaceutical and biotechnology companies worldwide. Each course, divided into 2-4 sections, consists of 20-30 lessons. Each lesson is a shareable content object (SCO), reusable by GeneEd, its partners and its clients as part of the exciting new paradigm of dynamic learning content delivery. GeneEd has sought the expertise of top scientific and medical experts for each content item, identified at medical schools, universities and private industry across the world, enabling each SCO to be treated as an independent, validated 'chunk' of knowledge.

Unlike the 'roll-and-scroll' static text and images commonly found at major e-health sites, GeneEd's Therapeutic Area e-learning database consists of dynamic Flash-based animations, which incorporate lucid expositions of disease state processes. Each animation is annotated with a voice-over, PDF transcript, and hypertext-linked glossary. (While the courses are currently available in U.S. English, GeneEd has expertise in localization to European and Asian languages and intends to release multiple language versions in the future.) Each course includes progress-checks, quizzes, and a final assessment, so learners can gauge their progress and understanding as they navigate the content. The lesson-objects have been added to GeneEd's content library of several thousand learning objects. Over 100 new web pages describing the courses have been uploaded to GeneEd's web-site, available at: http://www.geneed.com/expertise/ta.html.

In addition to the 130 new 'off-the-shelf' courses that GeneEd provides, each shareable content object (a.k.a. learning object) can now be rapidly assembled into customized courses based upon a client's specifications. This flexibility allows custom-specific courseware to be provided in an extremely cost-effective and timely manner. Clients using portions of GeneEd's disease-state database customized to their own specific needs include AstraZeneca, Amgen, Pfizer, Roche, Organon, Genentech and many others. Business partners who have commenced distributing the database with their own products and services include Campbell Alliance, RWD Technologies, Perkin-Elmer Life and Analytical Sciences and others.

The new disease-state database includes courses in the following therapeutic areas:

-- Cardiovascular System

-- Central Nervous System

-- Diabetes

-- Gastro-Intestinal System

-- Immune Diseases

-- Infectious Diseases

-- Musculoskeletal System

-- Oncology

-- Pain

-- Respiratory System

-- Urology

"The disease-state and therapeutic area library addresses a growing need within pharmaceutical companies to educate employees in modern biomolecular medicine that the new therapeutics are designed to address," said Dr. Sunil Maulik, GeneEd's co-founder. "While numerous academic organizations provide an excellent foundation for fundamental medical science, none have been effective at creating compelling e-Learning, validated for commercial use. We are changing that today by utilizing our Repurposing(TM) and Viewing(TM) engines and deep domain expertise to deliver dynamic, compelling disease-state e-learning to pharmaceutical, biotechnology and healthcare employees worldwide. As we continue to expand and update our content, we expect our industry-validated disease-state database to remain the standard for many years to come."

All GeneEd catalog and custom courseware are Continuing Medical Education (CME) Category One accredited and approved. GeneEd's courseware allow rapid technical integration into any organization's Learning Management System (LMS). All GeneEd E-Learning courses and learning objects are SCORM 1.2 compliant, and have been successfully integrated within 21CFR Part 11-compliant applications.

About GeneEd

GeneEd, Inc. was founded in 1997 to provide life science and healthcare e-Learning solutions for the pharmaceutical, biotechnology, instrument, medical device, and hospital/HMO industries. GeneEd's life science industry customers include AstraZeneca, Accenture, Amgen, GE-Healthcare, Pfizer, Johnson & Johnson, Roche, Sanofi-Aventis, Bio-Rad, Mayne Pharma and Genentech, amongst others. (http://www.geneed.com/customers.html)

GeneEd utilizes the best life science content, combined with advanced e-Learning development technology, to rapidly create basic and advanced curricula in the areas of genomics, disease state, drug discovery and development, pharmacogenomics, bioinformatics, and therapeutic and diagnostic products. GeneEd, Inc. is a privately held company headquartered in San Francisco, California. Visit http://www.GeneEd.com for additional information about GeneEd and its courseware.

(Flash is a trademark of Macromedia Corp/Adobe Inc.)

Source: Business Wire

More News in this Category